Gemina, Cyra Jane D.
HRN: 26-79-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2025
AMPICILLIN 250MG (VIAL)
03/17/2025
03/24/2025
IV
100mg
Q6H
Intraabdominal Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes